Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
76 participants
INTERVENTIONAL
2009-11-30
2011-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Haemodynamic Effects of Oxytocin and Carbetocin
NCT01277978
Carbetocin Compared To Oxytocin During Cesarean Delivery
NCT05758012
Effect of the Uterotonic Carbetocin on Acute Post Cesarean-Section Pain
NCT02642263
Comparison Of The Effects Of Carbetocin And Oxytocin In C-Sectıon
NCT05742854
Carbetocin Versus Oxytocin for Prevention of Postcesarean Hemorrhage in Pregnancy With High Risk for PPH
NCT04089176
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
carbetocin 100 µg
Carbetocin injection, 100µg, single injection
carbetocin 100 µg
Hemodynamic effect of
oxytocin 5 u
Oxytocin 5U, injection, single injection
oxytocin 5 u
Hemodynamic effect of
placebo (NaCl)
Saline single injection
placebo (NaCl)
Hemodynamic effect of
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
carbetocin 100 µg
Hemodynamic effect of
oxytocin 5 u
Hemodynamic effect of
placebo (NaCl)
Hemodynamic effect of
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Placenta disorders
18 Years
50 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Oslo University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Leiv Arne Rosseland
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Leiv Arne Rosseland, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Oslo University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Division of Anaesthesia and Intensive Care Medicine, Oslo University Hospital - Rikshospitalet
Oslo, , Norway
Division of Anesthesia and Intensive Care Medicine
Oslo, , Norway
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Rosseland LA, Hauge TH, Grindheim G, Stubhaug A, Langesaeter E. Changes in blood pressure and cardiac output during cesarean delivery: the effects of oxytocin and carbetocin compared with placebo. Anesthesiology. 2013 Sep;119(3):541-51. doi: 10.1097/ALN.0b013e31829416dd.
Michelsen TM, Tronstad C, Rosseland LA. Blood pressure and cardiac output during caesarean delivery under spinal anaesthesia: a prospective cohort study. BMJ Open. 2021 Jun 14;11(6):e046102. doi: 10.1136/bmjopen-2020-046102.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2009carb
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.